Acerus Pharmaceuticals (OTCMKTS:TRLPF) Shares Cross Above 200-Day Moving Average of $0.03

Acerus Pharmaceuticals Co. (OTCMKTS:TRLPF) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.03 and traded as high as $0.03. Acerus Pharmaceuticals shares last traded at $0.03, with a volume of 155,700 shares traded.

The firm has a fifty day moving average of $0.03 and a 200 day moving average of $0.03. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.35 and a quick ratio of 0.90.

About Acerus Pharmaceuticals (OTCMKTS:TRLPF)

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.

See Also: Pattern Day Trader – What is the PDT Rule?

Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.